Publication | Closed Access

Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)

Primary ImmunodeficiencyHuman RetrovirusTetanus Toxoid BoosterImmunologyActive Antiretroviral TherapyHiv-1-infected ChildrenAntiviral ResponseAutoimmunityHumoral ImmunityCd4 T Cell ResponsesChronic Viral InfectionHivImmunotherapyMedicine